BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31041834)

  • 1. Ultra-frequent HRAS p.Q61R somatic mutation in canine acanthomatous ameloblastoma reveals pathogenic similarities with human ameloblastoma.
    Peralta S; McCleary-Wheeler AL; Duhamel GE; Heikinheimo K; Grenier JK
    Vet Comp Oncol; 2019 Sep; 17(3):439-445. PubMed ID: 31041834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative transcriptional profiling of canine acanthomatous ameloblastoma and homology with human ameloblastoma.
    Peralta S; Duhamel GE; Katt WP; Heikinheimo K; Miller AD; Ahmed F; McCleary-Wheeler AL; Grenier JK
    Sci Rep; 2021 Sep; 11(1):17792. PubMed ID: 34493785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ki67 Labelling Index of Neoplastic Epithelial Cells Differentiates Canine Acanthomatous Ameloblastoma from Oral Squamous Cell Carcinoma.
    Peralta S; Grenier JK; McCleary-Wheeler AL; Duhamel GE
    J Comp Pathol; 2019 Aug; 171():59-69. PubMed ID: 31540626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of calretinin and cytokeratins in canine acanthomatous ameloblastoma and oral squamous cell carcinoma.
    Fulton A; Arzi B; Murphy B; Naydan DK; Verstraete FJ
    Vet Comp Oncol; 2014 Dec; 12(4):258-65. PubMed ID: 22985095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Confirmation of canine acanthomatous ameloblastoma using RAS Q61R immunohistochemical staining of formalin-fixed paraffin-embedded tissues.
    Peralta S; Marcinczyk MM; Katt WP; Duhamel GE
    Front Vet Sci; 2023; 10():1281022. PubMed ID: 37901104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear morphometry in canine acanthomatous ameloblastomas and squamous cell carcinomas.
    Martano M; Damiano S; Restucci B; Paciello O; Russo V; Maiolino P
    Eur J Histochem; 2006; 50(2):125-30. PubMed ID: 16864123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activating FGFR2-RAS-BRAF mutations in ameloblastoma.
    Brown NA; Rolland D; McHugh JB; Weigelin HC; Zhao L; Lim MS; Elenitoba-Johnson KS; Betz BL
    Clin Cancer Res; 2014 Nov; 20(21):5517-26. PubMed ID: 24993163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Mutational Profile of Unicystic Ameloblastoma.
    Heikinheimo K; Huhtala JM; Thiel A; Kurppa KJ; Heikinheimo H; Kovac M; Kragelund C; Warfvinge G; Dawson H; Elenius K; Ristimäki A; Baumhoer D; Morgan PR
    J Dent Res; 2019 Jan; 98(1):54-60. PubMed ID: 30216733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRAF V600E and previously unidentified KRAS G12C mutations in odontogenic tumors may affect MAPK activation differently depending on tumor type.
    Oh KY; Kim JH; Cho SD; Yoon HJ; Lee JI; Hong SD
    Genes Chromosomes Cancer; 2022 Aug; 61(8):481-490. PubMed ID: 35353428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Characterization of Canine Acanthomatous Ameloblastoma (CAA) in 263 dogs and the Influence of Postsurgical Histopathological Margin on Local Recurrence.
    Goldschmidt SL; Bell CM; Hetzel S; Soukup J
    J Vet Dent; 2017 Dec; 34(4):241-247. PubMed ID: 28978273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly recurrent BRAF p.V595E mutation in canine papillary oral squamous cell carcinoma.
    Peralta S; Webb SM; Katt WP; Grenier JK; Duhamel GE
    Vet Comp Oncol; 2023 Mar; 21(1):138-144. PubMed ID: 36451536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship of the canine acanthomatous epulis to ameloblastoma.
    Gardner DG; Baker DC
    J Comp Pathol; 1993 Jan; 108(1):47-55. PubMed ID: 8473558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of BRAFV600E and SMOF412E mutations in epithelial odontogenic tumours.
    Diniz MG; Gomes CC; Guimarães BV; Castro WH; Lacerda JC; Cardoso SV; de Faria PR; Dias FL; Eisenberg AL; Loyola AM; Gomez RS
    Tumour Biol; 2015 Jul; 36(7):5649-53. PubMed ID: 25854168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of cytokeratins in the epithelium of canine odontogenic tumours.
    Arzi B; Murphy B; Nemec A; Vapniarsky N; Naydan DK; Verstraete FJ
    J Comp Pathol; 2011 Nov; 145(4):345-51. PubMed ID: 21511272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Most canine ameloblastomas harbor HRAS mutations, providing a novel large-animal model of RAS-driven cancer.
    Saffari PS; Vapniarsky N; Pollack AS; Gong X; Vennam S; Pollack AJ; Verstraete FJM; West RB; Arzi B; Pollack JR
    Oncogenesis; 2019 Feb; 8(2):11. PubMed ID: 30741938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symphyseal-Sparing Mandibulectomy for Canine Acanthomatous Ameloblastoma in Dogs: 35 Cases.
    Bolek AM; Smith MM; Taney K; Powers B
    J Vet Dent; 2024 Jan; 41(1):10-16. PubMed ID: 37006121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequence analysis of RAS and RAF mutation hot spots in canine carcinoma.
    Mochizuki H; Breen M
    Vet Comp Oncol; 2017 Dec; 15(4):1598-1605. PubMed ID: 27714944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Canine acanthomatous epulis. The only common spontaneous ameloblastoma in animals.
    Gardner DG
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1995 May; 79(5):612-5. PubMed ID: 7600226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The landscape of genetic alterations in ameloblastomas relates to clinical features.
    Gültekin SE; Aziz R; Heydt C; Sengüven B; Zöller J; Safi AF; Kreppel M; Buettner R
    Virchows Arch; 2018 May; 472(5):807-814. PubMed ID: 29388014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenoid ameloblastoma with dentinoid is molecularly different from ameloblastomas and adenomatoid odontogenic tumors.
    Coura BP; Dos Santos JN; Fonseca FP; Bernardes VF; de Aquino SN; Jorge Júnior J; Vargas PA; Romañach MJ; de Andrade BAB; Gomez RS; Gomes CC
    J Oral Pathol Med; 2021 Nov; 50(10):1067-1071. PubMed ID: 34549835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.